Home World News Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based... World News Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP By Ogkologos - September 22, 2026 93 0 Facebook Twitter Google+ Pinterest WhatsApp Updated results after additional follow-up in the CUPISCO study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Advanced and Metastatic Prostate Cancer Living Guideline June 11, 2026 Cancer research could revive the UK’s ailing public finances November 16, 2022 Mezigdomide-Carfilzomib-Dexamethasone Prolongs PFS Compared with Carfilzomib-Dexamethasone at First Relapse in Patients... July 9, 2026 Trastuzumab Deruxtecan Demonstrates Durable Responses in Patients with Previously Treated HER2-mutated... September 27, 2023 Load more HOT NEWS EMA Recommends Granting a Conditional Marketing Authorisation for Idecabtagene Vicleucel ctDNA-Guided Therapy with Pertuzumab plus Trastuzumab for HER2-Amplified mCRC Toothbrushes and ctDNA: Exciting early detection concepts from new teams formed... EMA Recommends Extension of Indications for Ribociclib to Include Use in...
